On 2025-05-12, Immunome, Inc. (IMNM) announced earnings per share of $-0.52 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.66.
The next expected annoucement date for quarterly earnings is 2025-08-11, with an average estimated earnings per share of $-0.53 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-12 | 2025-03-31 | $-0.66 | $-0.52 |
| 2025-03-19 | 2024-12-31 | $-0.68 | $-0.84 |
| 2024-11-13 | 2024-09-30 | $-0.60 | $-0.78 |
| 2024-08-12 | 2024-06-30 | $-0.38 | $-0.49 |
| 2024-05-14 | 2024-03-31 | $-0.80 | $-0.34 |
| 2024-03-28 | 2023-12-31 | $-0.28 | $-0.54 |
| 2023-11-09 | 2023-09-30 | -- | $-0.36 |
| 2023-08-09 | 2023-06-30 | -- | $-0.46 |
| 2023-05-05 | 2023-03-31 | -- | $-0.35 |
| 2023-03-16 | 2022-12-31 | -- | $-0.64 |
| 2022-11-14 | 2022-09-30 | -- | $-0.75 |
| 2022-08-05 | 2022-06-30 | -- | $-0.74 |
| 2022-05-12 | 2022-03-31 | -- | $-0.96 |
| 2022-03-28 | 2021-12-31 | -- | $-0.66 |
| 2021-11-15 | 2021-09-30 | -- | $-0.65 |
| 2021-08-16 | 2021-06-30 | -- | $-0.46 |
| 2021-05-12 | 2021-03-31 | -- | $-0.37 |
| 2021-03-25 | 2020-12-31 | -- | $-0.40 |
| 2020-11-17 | 2020-09-30 | -- | $-2.54 |